MIT Media Lab project, Biota Beats, collects bacteria from different parts of the body and turns it into music, reports Erin Blakemore from The Washington Post. “The team crowdsources swabs from body parts — including mouths, feet, and armpits — then cultures the microorganisms on petri dish-like ‘records,’” Blakemore writes.
Inverse reporter Dan Robitzski writes that MIT researchers have created a new gel-like coating that can be used to make medical devices feel more natural. The researchers, “developed the hydrogels to manufacture products that feel like the part of the body they contact — say, a catheter that feels like the inside of a urethra.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have developed a new gel-like coating that can be used on medical devices like catheters and IV tubes to reduce friction and ease patient discomfort. The substance, “can be moved, stretched, and twisted without breaking, “Ducharme explains, and also, “acts as a lubricant for the objects it coats.”
Prof. Phillip Sharp speaks with WBUR’s Asma Khalid about how the Greater Boston area became a hub for the biotech industry. "I think one of the transformative parts of what the next 20 years will hold is engineering with medicine and biotech," Sharp explains, adding that he thinks the Greater Boston area is “ahead of that story."
During a panel discussion during the Koch Institute’s 16th Annual Cancer Research Symposium, participants discussed how the convergence of biology and engineering could accelerate treatments for cancer and other diseases, writes Robert Weisman for the Boston Globe. “To my mind, this is the 21st century’s innovation story,” said President Emerita Susan Hockfield.
MIT researchers have genetically engineered E.coli bacteria to replicate light and create images in a range of different colors, reports Alexandra-Simon Lewis for Wired. In the future, the technique could be used to make “bacteria produce more complex molecules on-demand by using light to stop and start chemical reactions.”
Washington Post reporter Travis Andrews writes that MIT researchers have created a workout suit with ventilating flaps embedded with bacteria that automatically open and close in response to sweat. Andrews explains that “as the bacteria relaxes and shrinks into itself, the cells pull away from the wearer, opening the flaps and letting fresh air flood in.”
New Scientist reporter Andy Coghlan writes that MIT researchers have engineered bacteria to produce full-color, living photocopies. Coghlan explains that the technique could “enable finer control of the bacteria grown in fermenters to churn out vital drugs, antibodies and materials. Another application could be using light to sculpt living biomaterials, such as tissues and organs for transplant.”
MIT researchers have developed a workout suit with vents that are triggered by bacteria to automatically open in response to sweat, reports Rob Verger for Popular Science. Verger explains that the researchers hope to apply the technology to create clothing that can, “produce a pleasant smell when you sweat.”
Daily Mail reporter Colin Fernandez writes that MIT researchers have developed a self-ventilating workout suit that can help keep athletes cool and dry while they exercise. Fernandez explains that the suit is embedded with harmless microbes that contract when they sense heat or cold, triggering flaps in the suit to open and close.
Wall Street Journal reporter James Hagerty writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation known for his work as a pioneering leader in the field of biotechnology.
Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a transformational leader in biotechnology of orphan diseases. Many children now have hope of a healthy life because of his vision and 40 years of creative business leadership.”
Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”
MIT spinoff Sample6 has raised $12.7 million to create a better system for detecting bacteria in food, writes Luke Timmerman for Forbes. “The company has developed a technology that can target specific bioparticles, light them up and do it without enriching the sample,” explains Timmerman.
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.